Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Comment by NothinButTimeon Jul 22, 2020 4:45pm
260 Views
Post# 31304271

RE:RE:RE:RE:wateroperator:

RE:RE:RE:RE:wateroperator:

You are correct that they haven't applied...yet.  Look at a company like MIR that applied in April, and still hasn't received approval 3 months later.  

Sona is going about this the right way.  They got validation from a top US lab that works with the FDA on a regular basis.  They are also doing field studies to backup their validation from MRI Global.  

They also have Sandy Morrison and Fiona Marshall on their team.  Sandy was involved in obtaining regulatory approval for the first rapid assay HIV test from both HC and FDA.  He has over 30 years in the medical device field and offers extensive experience in this department.

Fiona Marshall was involved in development and manufacturing of various lateral flow tests, including tests for class 3 deadly pathogens that served US military contracts.  She also oversaw the rapid test development in 2013 for the Ebola outbreak.  

These advisors aren't here to play games.  Sona is surrounded by all the right people and they absolutely are the real deal.  

Once they do apply, the FDA won't hesitate to approve a company with such an impressive resume, that made sure all their ducks were in a row BEFORE applying.  

The reason companies like MIR wait so long, is because they didn't take these steps.  Sona is doing everything right.  
 



TraderNmc wrote: SONA's test isn't even listed as one that is trying to get FDA approval; check this link...so they won't be able to sell it in the USA.
https://www.360dx.com/coronavirus-test-tracker-launched-covid-19-tests?fbclid=IwAR3onz86RfmjbMexMETUy5n5L1e-uXozv1Or7b2z4hjoyIIrPFwCIe2O1C0

 

<< Previous
Bullboard Posts
Next >>